Michael U.

Michael U. has extensive experience in accounting and finance, spanning across multiple industries and roles. Michael has worked as Corporate Controller and Vice President of Finance at Werewolf Therapeutics from 2023, as Senior Director, Corporate Controller and Head of Facilities at Codiak BioSciences from 2021 to 2023, and as Director of Finance & Corporate Controller at Indigo from 2019 to 2021. Prior to that, they held various senior positions at Philips, Babcock Power, KLR, RSM US LLP, and Feeley & Driscoll, P.C. Their responsibilities included overseeing accounting and financial reporting, managing teams, coordinating audits, monitoring compliance, designing and implementing policies, procedures and controls, and mentoring staff. Throughout their career, they have demonstrated the ability to develop and implement scalable best practices to support organizational growth.

Michael U. attended Assumption University from 1998 to 2002, where they earned a Bachelor of Science degree in Accounting and Finance. Michael has also obtained a certification as a Certified Public Accountant from an institution in MA, though the month and year of obtaining it are unavailable.